Latest news
Loading news…
KaliVir Immunotherapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Pittsburgh, Pennsylvania, United States Founded 2019 51-100 employees For Profit
KaliVir Immunotherapeutics develops oncolytic viral immunotherapy programs for the treatment of cancer.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
36
Patents
11
13 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 29
- Patents granted
- 11
- Trademarks
- 13
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $267K
Company Info
- Founded
- 2019
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 42
- HQ
- Pittsburgh, Pennsylvania, United States
- Region
- Great Lakes, Northeastern US
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- -0.4
- Trend (90d)
- -0.7
Key People at KaliVir Immunotherapeutics
Controller
Chief Executive Officer
36
professional contacts at KaliVir Immunotherapeutics
Contact execs at KaliVir Immunotherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to KaliVir Immunotherapeutics
Loading news…
FAQs about KaliVir Immunotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.